PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC) trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for groundbreaking cancer drug trial
Disease control Not yet recruitingThis is the first study in people to test a new drug called DA 3501 for advanced stomach and pancreatic cancers. The main goals are to find a safe and effective dose and to see how the body handles the drug. About 51 patients with specific types of these cancers will receive the …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Does draining bile before surgery help or hurt pancreatic cancer patients?
Knowledge-focused Not yet recruitingThis study aims to understand if draining a blocked bile duct before pancreatic cancer surgery affects how the cancer spreads and patient survival. Researchers will review the medical records of over 90 patients who had surgery between 2014 and 2022, comparing those who had the d…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Sponsor: East Lancashire Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC